Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on April 28, 2009
JNCI Journal of the National Cancer Institute 2009 101(9):613; doi:10.1093/jnci/djp142
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
101/9/613-b    most recent
djp142v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2009.

MEMO TO THE MEDIA

Gene Alterations Are Associated with Better Response to Anthracycline-Based Chemotherapy for Breast Cancer

The first 10% of the full text of this article appears below.

Alterations in the topoisomerase II alpha (TOP2A) gene were associated with better patient outcomes following anthracycline-based therapy compared with non-anthracycline-based regimens, according to a study in the April 28 online issue of the Journal of the National Cancer Institute. The increased responsiveness is similar to what is seen in patients whose tumors carry an . . . [Full Text of this Article]

Citations:

Contacts:


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
F. P. O’Malley, S. Chia, D. Tu, L. E. Shepherd, M. N. Levine, V. H. Bramwell, I. L. Andrulis, and K. I. Pritchard
J Natl Cancer Inst 2009 101: 644-650. [Abstract] [Full Text] [PDF]

Alterations in the TOP2A and HER2 Genes: Association With Adjuvant Anthracycline Sensitivity in Human Breast Cancers
Dennis J. Slamon and Michael F. Press
J Natl Cancer Inst 2009 101: 615-618. [Extract] [Full Text] [PDF]